(Q45856286)

17 December 2017

title

Co-expression of B7-1 with Interleukin-12 Enhances Vaccine-induced Antitumour Immunity in Experimental Myeloma (English)

1 reference

17 December 2017

author name string

T S Hawley

series ordinal

1

1 reference

17 December 2017

P S Linsley

series ordinal

2

1 reference

17 December 2017

R G Hawley

series ordinal

3

1 reference

17 December 2017

publication date

1 January 1998

1 reference

17 December 2017

published in

Hematology

1 reference

17 December 2017

volume

3

1 reference

17 December 2017

issue

5

1 reference

17 December 2017

page(s)

365-374

1 reference

17 December 2017

Growth control mechanisms in multiple myeloma

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10245332.1998.11746410

The treatment of multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245332.1998.11746410

The role of the CD28 receptor during T cell responses to antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245332.1998.11746410

Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245332.1998.11746410

Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245332.1998.11746410

Constitutive expression of B7 restores immunogenicity of tumor cells expressing truncated major histocompatibility complex class II molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245332.1998.11746410

Gene transfer of the costimulatory molecules B7-1 and B7-2 into human multiple myeloma cells by recombinant adeno-associated virus enhances the cytolytic T cell response

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245332.1998.11746410

Does B7-1 expression confer antigen-presenting cell capacity to tumors in vivo?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245332.1998.11746410

A reassessment of the role of B7-1 expression in tumor rejection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245332.1998.11746410

Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245332.1998.11746410

T cell costimulation by B7/BB1 induces CD8 T cell-dependent tumor rejection: an important role of B7/BB1 in the induction, recruitment, and effector function of antitumor T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245332.1998.11746410

Paracrine cytokine adjuvants in cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245332.1998.11746410

Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245332.1998.11746410

Antitumor and antimetastatic activity of interleukin 12 against murine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245332.1998.11746410

B7 and interleukin 12 cooperate for proliferation and interferon gamma production by mouse T helper clones that are unresponsive to B7 costimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245332.1998.11746410

Interleukin 12 synergizes with B7/CD28 interaction in inducing efficient proliferation and cytokine production of human T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245332.1998.11746410

Interleukin-12 and B7.1 co-stimulation cooperate in the induction of effective antitumor immunity and therapy of established tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245332.1998.11746410

Interleukin 12 and B7-1 costimulatory molecule expressed by an adenovirus vector act synergistically to facilitate tumor regression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245332.1998.11746410

Enhanced immunogenicity of B cell lymphoma genetically engineered to express both B7-1 and interleukin-12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245332.1998.11746410

Tumour cell expression of B7 costimulatory molecules and interleukin-12 or granulocyte-macrophage colony-stimulating factor induces a local antitumour response and may generate systemic protective immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245332.1998.11746410

Expression of Retrovirally Transduced IL-1 α in IL-6-Dependent B Cells: A Murine Model of Aggressive Multiple Myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245332.1998.11746410

Adhesion molecules involved in the binding of murine myeloma cells to bone marrow stromal elements

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245332.1998.11746410

Increased frequency of both total and specific monoclonal antibody producing hybridomas using a fusion partner that constitutively expresses recombinant IL-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245332.1998.11746410

Transplantable myeloproliferative disease induced in mice by an interleukin 6 retrovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245332.1998.11746410

Comparative analysis of retroviral vector expression in mouse embryonal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245332.1998.11746410

Lack of correlation between rejection of tumor cells co-expressing interleukin-2 and B7.1 and vaccine efficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245332.1998.11746410

Inhibition of angiogenesis in vivo by interleukin 12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245332.1998.11746410

Ras oncogene mutation in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245332.1998.11746410

Lysis of ras oncogene-transformed cells by specific cytotoxic T lymphocytes elicited by primary in vitro immunization with mutated ras peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245332.1998.11746410

Transfer of myeloma idiotype-specific immunity from an actively immunised marrow donor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10245332.1998.11746410

10.1080/10245332.1998.11746410

21 January 2018

Identifiers

DOI

1 reference

17 December 2017

PubMed ID

27414080

1 reference

17 December 2017